CIK 0001628908
- Large accelerated filer
Evolent Health, Inc.
Sign in to watch- Ticker
- EVH
- Exchange
- NYSE
- Industry
- Services-Management Services
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 320454912
- Phone
- +1 571-389-6000
- Business address
- 1812 NORTH MOORE ST, SUITE 1705, ARLINGTON, VA, 22209
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Accounting Officer acquired 25,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 80,000 shares (grant or award)
- 4 Grant or award Director acquired 5,219 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy President bought 14,749 shares at $6.73 ($99,261)
- 4 Open-market buy Chief Executive Officer bought 35,000 shares at $6.51 ($227,850)
- 4 Open-market buy Director bought 7,200 shares at $7.04 ($50,688)
- 4/A Open-market buy Director bought 10,000 shares at $12.45 ($124,500)
- 4 Open-market buy Director bought 15,000 shares at $7.03 ($105,450)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 14,156 shares (grant or award)
- 4 Grant or award Director acquired 14,156 shares (grant or award)
- 4 Grant or award Director acquired 14,156 shares (grant or award)
- 4 Grant or award Director acquired 14,156 shares (grant or award)
- 4 Grant or award Director acquired 14,156 shares (grant or award)
- 4 Grant or award Director acquired 14,156 shares (grant or award)
- 4 Grant or award Director acquired 14,156 shares (grant or award)
- 4 Open-market sale Director sold 10,000 shares at $12.25 ($122,500)
Page 12 of 22 · 421 filings